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Alpha-fetoprotein protein (AFP) is naturally found in fetal serum while production and appearance after 
birth is indicative of presence of malignant tumors. Therefore, by measuring this protein during fetal 
period and after birth, it is possible to diagnose abnormalities and tumors in fetus or the newborn. The 
objective of this study was to produce and purify AFP protein using DNA recombinant technology to 
apply in diagnostic kit preparations. In this study Pichia pastoris as metylotrophic yeast was used for 
AFP production. After construction of recombinant plasmid, pS1-AFP, electroporation and lithium 
chloride techniques were used for transferring to susceptible cells. The quantity and quality of the 
produced protein were checked by SDS-PAGE and ELISA methods. Selection of transformed mutant 
strains of Muts and culturing them in glycerol media (YPG) up to OD600=6 and their transfer to methanol 
media (YPM) with augmentation of methanol to 1% final concentration resulted in inducing protein 
production in auxotrophic media lacking histidine. This protein could be useful in monoclonal antibody 
production and in diagnostic kit preparations. 
 





Alpha-fetoprotein protein (AFP) is a major serum protein 
synthesized during fetal life by fetal liver and yolk sac 
(Abelev, 2001). After birth it disappears from the 
circulation and its reappearance of AFP in adult serum 
often signals pathological conditions, particularly 
hepatocarcinomas and teratocarcinomas (Filmus et al., 
2004). AFP blood level change is an important marker for 
liver tumors that is widely used in clinical practice. 
Therefore,  the   study   of   the   molecular   and   cellular 
mechanisms participating in regulation of the 
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The AFP gene belongs to albumin gene family 
(Gabant et al., 2002). All of them are synthesized in liver 
and secreted into blood serum, providing delivery of their 
bound ligands to different tissues. Albumin and AFP 
genes are located on chromosome 5 of mouse (Yang et 
al., 1990), 14 of rat (Remmers et al., 1993), and on the 
long arm of chromosome 4 of human (4q11-q13) (Song 
et al., 1999). They indicate that the closely related AFP 
and albumin genes are constituted by 15 exons 
containing about 2 kb of DNA and 14 introns with 
approximately 20 kb. With investigation of cDNA obtain 
from human Alpha-fetoprotein mRNA, three important 
parts are recognized: 44 non-coding nucleotides at the 
5´ end, 1830 coding nucleotides and 155 non-coding 
nucleotides at the 3´ end (Peyton et al., 2000).  
All the products of AFP gene transcription can be 
translated.    The    2.1    kb    nmRNA    corresponds    to  
  




polypeptides weighing 68 and 70 kD (Karamova et al., 
2003), that was shown like a single band by 
electrophoresis. The amino acid sequence was deduced 
from the nucleotide sequence, which revealed 19 amino 
acids in the signal sequence and 590 amino acids in 
mature AFP and with 4% carbohydrate residues. It is a 
secretory protein and it is linked by disulfide bridges 
make tube structures that have especial places for 
ligands linking (Morinaga et al., 1983).  
On various experimental models, it has been shown 
that the expression is regulated mainly on the 
transcriptional level, the AFP gene having a 7 kb 
regulatory region upstream. Within this region, a tissue-
specific promoter, three independent enhancers and a 
silencer (that is at least partially responsible for AFP gene 
expression decrease in adult liver) have been defined. 
Studies on the correlation of the methylation level of the 
AFP gene or its regulatory region and the gene 
expression level have given contradictory results (Hasse 
et al., 1994). 
The use of DNA recombinant technology method for 
producing human alpha-fetoprotein was started by 
Giuliani in prokaryotes (Giuliani et al., 1989). But because 
of some difficulties in prokaryote expression system 
(such as non-production of AFP protein complete 
structure and inclusion bodies), the eukaryote expression 
system is preferred. One of the eukaryote that has been 
used to produce foreign proteins such as AFP is yeast. 
Methylotrophic yeasts are widely used as organisms for 
the production of recombinant heterogonous proteins 
(Cereghino et al., 2000). As unicellular eukaryotic 
organisms they combine the advantages of simplicity of 
molecular genetic manipulation with the ability to 
introduce post-translational eukaryotic modifications into 
protein products or foreign proteins (Minic et al., 2005). 
The use of strong and tightly regulated methanol-
inducible promoters allows for controlled induction of 
recombinant gene expression and the generation of high 
yields of the foreign proteins. In Pichia pastoris, alcohol 
oxidase (AOX) is the first enzyme in the methanol 
utilization pathway and   encoding by two genes, AOX1 
and AOX2. Regulated expression can be obtained with 
the AOX1 promoter. The use of the AOX1 promoter has 
yielded expression levels that were either very high (on 
methanol) or very low (on glucose or other carbon 
sources) (Waterham et al., 1997). P. pastoris has been 
shown to be a suitable host for the industrial production 
of hetrologous glycoproteins (Sreekrishna et al., 1997). In 
this paper we report a high level expression of human 
AFP in P. pastoris. 
 
 
MATERIALS AND METHODS 
 
Strains and growth conditions 
 
P. pastoris strains GS115 (His4) was provided by the Invitrogen 
company. Strain GS115 is the original His-deficient mutant strain 





derived from GS115 was constructed by replacing the AOX1 gene 
with the HIS4 gene, and was used to make the diploid strain. P. 
pastoris strain (GS115/-galactosidase) is provided as a His+ Mut+ 
intracellular expression control. Growth of strain during Mut+ 
expression provides a positive control for expression conditions. P. 
pastoris strain (GS115/Albumin) is provided as a His+ Muts 
intracellular expression control (Invitrogen, San, Diego). 
Yeast strains were grown at 30°C either in YPD medium [1% 
(w/v) yeast extract, 2% (w/v) peptone or krypton, 1% (w/v) dextrose] 
, YPM medium [1% (w/v) yeast extract, 2% (w/v) peptone, 0.5% 
(v/v) methanol] , YPG medium [1% (w/v) yeast extract, 2% (w/v) 
peptone, 1% (v/v) glycerol] , or minimal media containing 1.34% 
(w/v) yeast nitrogen base without amino acids and with ammonium 
sulfate, 0.5% (w/v) supplemented with one of the following: 0.5% 





Escherichia coli strain JM109 (Invitrogen, San, Diego) was used in 
all cloning procedures involving plasmid propagation. Polymerase 
chain reaction (PCR), plasmid isolation, restriction analysis, cloning 
techniques, transformation of E. coli and isolation of genomic DNA 
were performed according to standard protocols (van Passel et al., 
2004). Taq2000 DNA polymerase (Taq Stratagene. La Jolla, CA) 
was used for all PCR reactions. PCR was conducted in 30 cycles of 
1 min at 94°C (2 min for the first cycle), of 1 min at 55°C, and of 1 
min at 72°C (7 min for the last cycle). 
Yeast cells were transformed by electroporation and lithium 
chloride (Clemson et al., 2003). This procedure was adapted from 
the method of Beacker and Guarente (1991). A 50-ml culture of 
GS115, a His4 auxotophic strain of P. pastoris (Gould et al, .1992), 
was grown in YPD at 30°C with good aeration to an OD600 of 1-2. 
The culture was supplemented with 1 ml of 1.0 M-Na + -HEPES, pH 
8.0 and 1 ml of 1.0 M-DTT, and incubation was continued for an 
additional 15 min. The cells were transferred to a chilled 50-ml 
Falcon tube, centrifuged for 3 min at 2000 g in a tabletop centrifuge 
at 4°C, and resuspended  in 50 ml ice-cold double-distilled H2O. 
This H2O wash step was repeated, followed by a wash with 20 ml 
cold 1.0 M-sorbitol. Finally, the cells were resuspended in 200 µl 
cold 1.0 M-sorbitol. A 40-µl aliquot of yeast cells was mixed with 
0.1-1 µg DNA in  5 µl of a low-salt solution. This mixture was 
transferred to a chilled electroporation cuvette (0.2 cm gap) and 
pulsed with a Bio-Rad Gene Pulser set at 1.5 KV , 25 µF, 200 ohms  
(time constant ~ 5 ms). The cell suspension was immediately 
diluted with 1 ml of cold 1.0 M-sorbitol and transferred to a 1.5- ml 
centrifuge tube. After centrifugation for 1 min at 2000 g in a 
microfuge at room temperature, the upper 800 µl of liquid was 
removed and the cells were gently resuspended in the remaining 
volume. Finally, the cells were spread on YND - His- plates 
supplemented with 1.0 M-sorbitol, and the plates were incubated at 
30°C for 2-3 days until colonies appeared.  
A 50-ml culture of GS115 in YPD at 30°C preparated for lithium 
chloride transformation method. After washing with sterile water, 
sterile TE buffer (10 mM Tris-HCl, pH 7.4, 1 mM EDTA, pH 8.0) , 
sterile TE buffer/LiCl  (0.1 mM LiCl ,10 mM Tris-HCl, pH 7.4, 1 mM  
EDTA) and incubate the tube at  30°C for one hour. For each 
transformation sample, the following were added to a sterile 1275 
mm polypropylene tube:  0.1 to 20 g of transforming DNA and 0.1 
ml of competent GS115 cells. After incubating the tube at 30°C for 
30 min, 0.7 ml of 40% polyethylene glycol (PEG-3350) in TE 
buffer/LiCl was added and vortexed briefly to mix. The samples 
were heat shocked at 37°C for 5 min and spread on selective plates 
such as YNM medium. Incubation of the plates was for 2-3 days at 









































Figure 1. Constraction of expression vectors. PUC 18 and AFP cDNA were digested with EcoRI and BamHI and subsequently was 
isolated by preparative agarose gel electrophoresis and ligated to give pUC-AFP. pHIL-S1, a plasmid vector that for expression 
AFP cDNA in yeast. The 1.8 kb AFP cDNA fragment from pUC-AFP was inserted at the same sites (EcoRI and BamHI) of pHIL-S1 




For screening for Muts and Mut+ transformants, GS115 cells with 
Bgl II and Sal I – linearized pHIL-S1 constructs favor recombination 
at the AOX1 and HIS4 locus. Most of the  transformants  should  be 
Mut+; however, with presence of the AOX1 sequences in plasmid, 
there is a chance that recombination will occur at the AOX1 locus, 
disrupting the wild-type AOX1 gene and creating His+Muts 
transformants. Displacement of the AOX1 structural gene occurs at 
a frequency of 5-35% of His+ transformants. By patching or replica-
plating on minimal dextrose (YND) versus minimal methanol (YNM) 
plates, Muts and Mut+ transformants can be readily distinguished. 
Because Muts transformants are not producing alcohol oxidase (the 
product of the AOX1 gene), they cannot efficiency metabolize 
methanol as a carbon source and therefore grow poorly on YNM 
medium. This slow gene has been disrupted (His+Muts) from His+ 




Subcloning of the AFP gene and construction of the yeast 
expression vector pHIL-S1 
 
The subcloning strategy is depicted in Figure 1. The 1779 bp 
fragment of AFP gene, were amplified using the primers 5'-
GCCGGAATTCACACTGCATAGAAATGAATATGG-3'     (F-AFP; 
upstream primer including an EcoRI site),                                                          
5'-CGCGCCTAGGAATTTGAGGGTTTCGTCGTGCTC-3' (R-AFP; 
downstream primer including a BamHI site). After phenol/chloroform 
extraction and ethanol precipitation, the amplified products were 
subjected to agarose gel electrophoresis and extracted from the 
gel. The 1779 bp fragment of AFP gene and cloning vector (PUC 
18) digested with EcoRI and BamHI, and then ligated to generate 
the recombinant plasmid (PUC18-AFP). After preparation, plasmid 
was transformed under heat shock (42°C) and calcium chloride for 
90 s into E. coli (Invitrogen, Carlsbad, CA). Extraction and 
purification of subcloned plasmid were done using SDS (1%), 
NaOH (0.02 N), acetate sodium (3M) (Clemson et al., 2003). 
PHIL-S1 is an E. coli/P. pastoris shuttle vector capable of 
expressing the P. pastoris AOX1 gene. Ps1-AFP was constructed 
as follows: First, the AFP fragment was digested with EcoR I and 
BamH I enzymes of plasmid PUC18-AFP. This resulted in a 
fragment with an EcoRI site at the 5' terminus and a BamHI site at 
the 3' terminus. Second, expression vector pHIL-S1 as well as 
digested with EcoRI and BamHI. Subsequently, the AFP fragment 
was inserted into the same sites to create Ps1-AFP. The plasmid 
was linearlized within the AOX1 promoter region by digestion with 
BglII and SalI prior to transformation into P. pastoris. 
  






Figure 2. Analyses of AFP genes by agarose gel electrophoresis.  (A) Agarose gel (1%) stained by ethidium bromide 
after electrophoresis. Lane 1, pHIL-S1 digested with EcoRI and BamHI; Lane 2, size marker (1 kb); and lane 3, AFP 
fragment digested with EcoRI and BamHI. (B) Lane 1, pUC-AFP digested with EcoRI and BamHI; lane 2, size marker 




Expression of AFP cDNA in yeast 
 
The expression vector (Ps1-AFP) was BglII digested and the 
expression cassette transformed in to histidine-requiring auxotroph 
(His-) GS115 P. pastoris strain which acquired a His+ phenotype 
following transformation. The transformed cells were analyzed by 
screening P. pastoris strains (GS115/ His+ Mut+ and GS115/ His+ 
Muts) on YNM medium , to check  for correct integration by 
replacement of the P. pastoris host AOX1 gene by expression 
cassette of the Ps1-AFP and to assure stable expression of a single 
integrant. 
P. pastoris cells expressing AFP were grown in shake flask with 
50  ml of  YPG medium (10 g yeast extract, 20 g peptone, and 2% 
(w/v) of glycerol) at 30°C until OD600 of 5 – 10. Then they were 
harvested, washed once with YP (glycerol free YPG medium), 
resuspended in YP at approx. OD600 5 and incubated at 30°C for 3 
to 4 days with methanol to induce expression. The culture media 
from methanol induced transformants were tested to assess the 
percentage of AFP expression by densitometric scanning of the 
coomassie brilliant blue stained protein bands fractioned by SDS-
PAGE using a LKB laser densitometer and also determined by 
ELISA. Temperature was maintained at 30°C. Cell yields were 
estimated by the wet cell pellet weight. Inoculations for the 
bioreactor runs were grown in a 1 L Erlenmeyer flask containing 
500 ml of YPG medium. Bioreactor cultures grown in the batch 
mode were propagated in YPG medium until the available glycerol 
was exhausted, then methanol was added to the culture for 96 h at 
a rate of 2.5 ml - 1 L for batch mode bioprocess. 
Yeast cells were washed once in disruption buffer (50 mM 
sodium phosphate, 5 mM EDTA, 10% sucrose, 0.3 M NaCl, 1 mM 
2-mercaptoethanol, pH 7) and resuspended in the same buffer at a 
concentration of 350 g/l. The cells were disrupted for 14 min on a 
bead mill (Dynomill) equipped with a cold water cooling jacket at a 
flow rate of 20 ml/min. The pellet with 1 liter of washing buffer (50 
mM sodium phosphate, 5 mM EDTA, 0.5% Triton X-100, 0.3 M  
NaCl, 1 mM 2-mercaptoethanol, pH   7), was centrifuged at 9000 g 
for 20 min and subjected to another three washings with a buffer 
containing 50 mM sodium phosphate, 5 mM  EDTA, 0.5% Triton X-
100, 0.3 mM  NaCl,  1  mM  2-mercaptoethanol, pH 7. 
 
  
Preparation of crude yeast lysates 
 
Yeast cells were washed with sterile ice-cold water and harvested 
by centrifugation. The cell pellets were resuspended in an equal 
volume of 50 mM Tris-HCl, pH 7 with 0.2 mM PMSF and 5µg/ml 
leupeptin as protease inhibitors. 1 ml of the suspension was mixed 
with 500 µl of acid-washed glass beads and vortexed for 5 min. Cell 
debris was pelleted for 20 s at maximal speed in an Eppendorf 
centrifuge and the clear supernatant representing the crude cell 
lysate was used for biochemical analysis.   
 
 
RESULTS AND DISCUSSION 
 
Subcloning of the AFP gene and construction of the 
yeast expression vector pHIL- S1 
 
AFP gene fragment which has restriction point of EcoRI 
and BamHI were inserted in polyclonal site (PCS) in 
pUC18 plasmid. JM109 competent cells were used for   
transformation and cultured in LB media containing AMP. 
In addition some colony as a positive control was 
obtained. Using alkaline procedure, recombinant 
plasmids of PUC-AFP from transformed cells were 
isolated and then restriction enzymes ( Bam HI, EcoRI) 
were applied for further clarification and the fragments 
with length of 1779 bp and 2665 bp were ran on agarose 
gel electrophoresis (Figure 2A). The colonies which 
contain plasmids, pHIL-S1 and pUC-AFP, were cultured 
in LB media in large scale.  Expression  vector,  pHIL-S1, 
was linearized by using restriction enzymes as mentioned 
above and confirmed on 1% gel agarose electrophoresis 
(Figure 2B). Recombinant plasmid ps1-AFP was 
constructed by T4 DNA ligase enzyme. For propagation 
  




          Table 1. Screening of transformed cells with pS1-AFP by YPD, MD, MM media. Positive marks shows high growth of  





YPD MD MM Number of 
transforming 
colony 
YPD MD MM 
 + + + + + +  + ++ + + + + + 
2 + ++ + + + + 18 + + + + + + 
3 _++ + + - 19 + + + + + + 
4 + + + + + + + 20 + + + + + + 
5 ++ + + + 21 + + + + + + + + + 
6 + ++ + + + + + 22 + + + + + + 
7 + ++ + + + + 23 + + + + + + 
8 _ _ _ 24 + ++ + + + + + 
9 + + + + + + + + + 25 ++ + + + + 
10 ++ + + + 26 + + + + + + 
11 +++ + + - 27 + ++ + + + + + 
12 + ++ + + + + 28 + ++ + + + + + 
13 + + + + + + + 29 + + + + + + + + 
14 + + + + + + 30 + + + + + + 
15 + + + + + + Control Muts +++ + + + - 
16 ++ ++ ++ Control Mut+ ++ +++ +++ 















   
Figure 3. Analyses of expressed AFPs by 12% SDS-
polyacrylamide gel electrophoresis. Coomassie blue-stained 
showing total cell extracts from GS115 P. pastoris strain induced 
with methanol, in each lane were loaded 100 g of total protein. 
Apparent molecular weight for human AFP is 69 kDa. M, 
molecular weight marker; S, cell extract; E, before induction; PT, 





of recombinant plasmid, JM109 strain was transformed 
by heat shot method and then cultured in LB media 
containing Apicillin. Before transforming in yeast cells for  
protein production, restriction mapping was carried out by 
using restriction enzymes such as BamHI, ECoRI and 
pVU II. For creating a stable recombinant, homologous 
regions between pS1-AFP and yeast genome were 
applied. For this purpose, above mentioned plasmid was 
cut by using BgIII enzyme and of this cut two different 
fragments were obtained. The fragment with 2870 bp had 
f1 ori and Ampr region and the fragment with 7190 bp 
which contain AFP gene insert had 5’ Aox1, HIS4, and 3’ 
AOX1. The big fragment was isolated from gel and 
transformed into GS115/HIS strain. Using lithium chloride 
method and transporation methods 5 and 100 colonies 
were obtained, respectively. Two recombinant strains, 
His+Mut+ and His+ Muts based on big fragment insertion 
became linear in AOX1 region of yeast genome. From 
selected colonies, a few of them were recognized as 
His+Muts phenotype (Table 1). Based on screening on 
culture media (YPD, MD, and MM) mutants form like Mut+ 
were recognized in plates 3, 11, and 25 in comparison to 
controls  and other colonies were determined as Mut+. 
For exploring AFP gene linking in yeast genome, PCR 
was done by using special primers. 
 
 
Expression of AFP cDNA in yeast 
 
Based on using pHIL-S1 plasmid and acid phosphatase 
secretory signals before AFP gene in yeast genome, it is 
expected that the produced protein should be secreted. 
Therefore, after methanol induction at 0, 24, 48, 72, 96, 
120 h, induced cell suspensions were centrifuged and 
then electrophoresis was carried out on 12% SDS-PAGE 
and then stained by comassie blue (Figure 3). The 
obtained fragment on lane PT is indication of this 
secretory protein. For evaluation of AFP production, 
immunoassay  procedure  (ELISA)  was  used  and   AFP  
  




protein concentration was measured within and outside 
the cell and the concentration were 10 and 2 ug/ml, 
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Alpha-fetoprotein could be evaluated by immunological 
methods in fetal serum and in normal individual. 
Production of specific antibodies against AFP has 
diagnostic value in different condition particularly tumoral 
and non-tumoral disorders. Initially, for the production of 
recombinant AFP protein, prokaryotic systems such as E. 
coli were used (Nishi et al., 1988). However, AFP is a 
eukaryotic protein and has specific characteristics which 
prokaryotic systems cannot process efficiency. Therefore, 
production in a simple eukaryotic system (yeast) is 
required (Yamamoto et al., 1995). At Iranian Pasteur 
Institute, AFP gene was constructed under 
phosphoglycerate kinase promoter  in  S. cerevisiae   and 
for each ml of cultured media 1 ug recombinant AFP  
protein was obtained which had similar physicochemical 
characteristic to native one (Shahbazzadeh et al., 1995). 
However, for increasing productivity and stability of AFP 
protein, methylotroph P. pastoris yeast is needed. We 
recommend the use of a fermenter for increasing of the 
product ratio. The expressed AFP could be used for 
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